129 related articles for article (PubMed ID: 28152008)
1. Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method.
Takase Y; Usui K; Shimizu K; Kimura Y; Ichihara T; Ohkawa T; Atsumi J; Enokida Y; Nakazawa S; Obayashi K; Ohtaki Y; Nagashima T; Mitani Y; Takeyoshi I
PLoS One; 2017; 12(2):e0171225. PubMed ID: 28152008
[TBL] [Abstract][Full Text] [Related]
2. Eprobe-mediated screening system for somatic mutations in the KRAS locus.
Atsumi J; Hanami T; Enokida Y; Ogawa H; Delobel D; Mitani Y; Kimura Y; Soma T; Tagami M; Takase Y; Ichihara T; Takeyoshi I; Usui K; Hayashizaki Y; Shimizu K
Oncol Rep; 2015 Jun; 33(6):2719-27. PubMed ID: 25823645
[TBL] [Abstract][Full Text] [Related]
3. Developing a New qPCR-Based System for Screening Mutation.
Zhu J; Zhao Y; Liu M; Gonzalez-Rivas D; Xu X; Cai W; Qi H; Dai L; Wang Z; Song X; Jiang G; Yang Y
Small; 2019 Mar; 15(9):e1805285. PubMed ID: 30677225
[TBL] [Abstract][Full Text] [Related]
4. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
[TBL] [Abstract][Full Text] [Related]
5. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
[TBL] [Abstract][Full Text] [Related]
6. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
[TBL] [Abstract][Full Text] [Related]
7. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process.
Hoshi K; Takakura H; Mitani Y; Tatsumi K; Momiyama N; Ichikawa Y; Togo S; Miyagi T; Kawai Y; Kogo Y; Kikuchi T; Kato C; Arakawa T; Uno S; Cizdziel PE; Lezhava A; Ogawa N; Hayashizaki Y; Shimada H
Clin Cancer Res; 2007 Sep; 13(17):4974-83. PubMed ID: 17785547
[TBL] [Abstract][Full Text] [Related]
9. [Screening for EGFR mutations in lung cancer by a novel real-time PCR with double-loop probe and Sanger DNA sequencing].
Zhang HP; Ruan L; Zheng LM; Bai DY; Zhang HF; Liao YQ; Ding Y
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):28-32. PubMed ID: 23648296
[TBL] [Abstract][Full Text] [Related]
10. HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
Pillai RN; Behera M; Berry LD; Rossi MR; Kris MG; Johnson BE; Bunn PA; Ramalingam SS; Khuri FR
Cancer; 2017 Nov; 123(21):4099-4105. PubMed ID: 28743157
[TBL] [Abstract][Full Text] [Related]
11. Clinical next-generation sequencing in patients with non-small cell lung cancer.
Hagemann IS; Devarakonda S; Lockwood CM; Spencer DH; Guebert K; Bredemeyer AJ; Al-Kateb H; Nguyen TT; Duncavage EJ; Cottrell CE; Kulkarni S; Nagarajan R; Seibert K; Baggstrom M; Waqar SN; Pfeifer JD; Morgensztern D; Govindan R
Cancer; 2015 Feb; 121(4):631-9. PubMed ID: 25345567
[TBL] [Abstract][Full Text] [Related]
12. Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction.
Oskina N; Oscorbin I; Khrapov E; Boyarskikh U; Subbotin D; Demidova I; Imyanitov E; Filipenko M
Mol Diagn Ther; 2017 Oct; 21(5):555-562. PubMed ID: 28589341
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay.
Endo K; Konishi A; Sasaki H; Takada M; Tanaka H; Okumura M; Kawahara M; Sugiura H; Kuwabara Y; Fukai I; Matsumura A; Yano M; Kobayashi Y; Mizuno K; Haneda H; Suzuki E; Iuchi K; Fujii Y
Lung Cancer; 2005 Dec; 50(3):375-84. PubMed ID: 16199108
[TBL] [Abstract][Full Text] [Related]
14. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS; Lawson DH; Delman KA; El-Rayes BF; Wilson MM; Sullivan HC; Morrison AS; Balci S; Adsay NV; Gal AA; Sica GL; Saxe DF; Mann KP; Hill CE; Khuri FR; Rossi MR
J Mol Diagn; 2016 Mar; 18(2):299-315. PubMed ID: 26801070
[TBL] [Abstract][Full Text] [Related]
15. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
Hinrichs JW; van Blokland WT; Moons MJ; Radersma RD; Radersma-van Loon JH; de Voijs CM; Rappel SB; Koudijs MJ; Besselink NJ; Willems SM; de Weger RA
Am J Clin Pathol; 2015 Apr; 143(4):573-8. PubMed ID: 25780010
[TBL] [Abstract][Full Text] [Related]
16. Detection of EGFR mutations in patients with non-small cell lung cancer by high resolution melting. Comparison with other methods.
Martínez-Carretero C; Pascual FI; Rus A; Bernardo I
Clin Chem Lab Med; 2017 Oct; 55(12):1970-1978. PubMed ID: 28432840
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive and specific real-time PCR by employing serial invasive reaction as a sequence identifier for quantifying EGFR mutation abundance in cfDNA.
Xiang Z; Wan R; Zou B; Qi X; Huang Q; Kumar S; Pitman JL; Zhou G; Song Q
Anal Bioanal Chem; 2018 Oct; 410(26):6751-6759. PubMed ID: 30128808
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an ultra-high sensitive next-generation sequencing assay for molecular diagnosis of clinical oncology.
Liang J; She Y; Zhu J; Wei L; Zhang L; Gao L; Wang Y; Xing J; Guo Y; Meng X; Li P
Int J Oncol; 2016 Nov; 49(5):2088-2104. PubMed ID: 27826616
[TBL] [Abstract][Full Text] [Related]
19. Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancer.
Masago K; Fujita S; Hata A; Okuda C; Yoshizumi Y; Kaji R; Katakami N; Hirata Y; Yatabe Y
Pathol Int; 2018 Mar; 68(3):167-173. PubMed ID: 29341374
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
